Antibodies Contract Manufacturing Market is expected to reach USD 35.9 billion by 2030
Antibodies Contract Manufacturing Industry Overview The global antibodies contract manufacturing market size was valued at USD 12.0 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 13.1% during the forecast period. The rising emphasis of biopharmaceutical & biotechnology companies on the production of antibody therapeutics is the primary factor driving the growth. These therapeutics are extremely effective in the treatment of cancer, rheumatoid arthritis, and other chronic diseases. Consequently, there is a surge in demand for the production of therapeutic antibodies, leading to the growth of the market. Moreover, monoclonal antibody therapy is used as a treatment for COVID-19, leading to an increase in the demand for antibody production. The ongoing COVID-19 pandemic has positively impacted the market. Gather more insights about the market drivers, restrains and growth of the Global Antibodies Contract Manufacturing Market As ...